Rifamycin SV-MMX® 600 mg Tablets Administered Three or Two Times Daily to Patients With IBS-D

NCT03099785 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

279

Enrollment

INDUSTRY

Sponsor class

Conditions

Diarrhea-predominant Irritable Bowel Syndrome

Interventions

DRUG: Rifamycin SV 600mg t.i.d.
DRUG: Rifamycin SV b.i.d. + Placebo
DRUG: Placebo t.i.d.

Sponsor

Cosmo Technologies Ltd